Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

Expression of an efficient small molecular weight tumour necrosis factor/lymphotoxin antagonist.

TNF-alpha and lymphotoxin are proinflammatory cytokines that are non-homologous in sequence, have similar homotrimeric structure and they exert their biological activity by aggregating two types of shared cell surface receptors. The natural inhibitors of TNF and lymphotoxin are the shed extracellula...

Full description

Bibliographic Details
Main Authors:	Neve, R, Kissonerghis, M, Clark, J, Feldmann, M, Chernajovsky, Y
Format:	Journal article
Language:	English
Published:	1996

Similar Items

Comparison of patterns of expression of tumour necrosis factor, lymphotoxin and interleukin-6 mRNA.
by: Turner, M, et al.
Published: (1988)

HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin.
by: Pujol-Borrell, R, et al.
Published: (1987)

Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
by: Corcoran, A, et al.
Published: (1994)

Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents.
by: Foxwell, B, et al.
Published: (2003)

Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.
by: Clark, T, et al.
Published: (2009)

The tumor necrosis factor superfamily members TNFSF14 (LIGHT), lymphotoxin β and lymphotoxin β receptor interact to regulate intestinal inflammation
by: Giles, DA, et al.
Published: (2018)

Arming ColoAd1 with tumor necrosis factor alpha and lymphotoxin alpha
by: Koelen, J
Published: (2015)

Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
by: Kissonerghis, A, et al.
Published: (1989)

The murine p75 TNF receptor promoter region: DNA sequence and characterization of a cis-acting silencer.
by: Kissonerghis, M, et al.
Published: (1999)

The effect of HLA-DR on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor haplotype.
by: Newton, J, et al.
Published: (2003)

DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene.
by: Nedospasov, SA, et al.
Published: (1991)

Cloning, expression and cross-linking analysis of the murine p55 tumor necrosis factor receptor.
by: Barrett, K, et al.
Published: (1991)

Family-based analysis of tumor necrosis factor and lymphotoxin-alpha tag polymorphisms with type 1 diabetes in the population of South Croatia.
by: Boraska, V, et al.
Published: (2009)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
by: Feldmann, M
Published: (1996)

Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils
by: Riffelmacher, T, et al.
Published: (2021)

The effects of pressure on chondrocyte tumour necrosis factor receptor expression.
by: Westacott, C, et al.
Published: (2002)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
by: Brennan, F, et al.
Published: (1995)

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
by: Williams, R, et al.
Published: (2000)

Localization of the genes for tumor necrosis factor and lymphotoxin between the HLA class I and III regions by field inversion gel electrophoresis.
by: Ragoussis, J, et al.
Published: (1988)

Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor.
by: Chernajovsky, Y, et al.
Published: (1995)

Tumour necrosis factor.
by: Van Der Merwe, P
Published: (1988)

Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
by: Corcoran, A, et al.
Published: (1998)

Overexpression of lymphotoxin in T cells induces fulminant thymic involution.
by: Heikenwalder, M, et al.
Published: (2008)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
by: Buchan, G, et al.
Published: (1988)

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.
by: Taylor, P, et al.
Published: (2004)

Gene therapy for chronic relapsing experimental allergic encephalomyelitis using cells expressing a novel soluble p75 dimeric TNF receptor.
by: Croxford, J, et al.
Published: (2000)

Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease
by: Per Andersson, et al.
Published: (2022-01-01)

Structure of tumour necrosis factor.
by: Jones, E, et al.
Published: (1989)

Avascular tumour dynamics and necrosis
by: Please, C, et al.
Published: (1999)

[Cloning and characteristics of the human genome locus containing genes of a second type of receptor (75 kDa) for tumor necrosis factor and lymphotoxin]
by: Turetskaia, R, et al.
Published: (1991)

Cloning and characteristics of the human genome locus containing genes of a second type of receptor (75 kDa) for tumor necrosis factor and lymphotoxin
by: Turetskaia, R, et al.
Published: (1991)

Soluble lymphotoxin is an important effector molecule in GVHD and GVL.
by: Markey, K, et al.
Published: (2010)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
by: Maini, R, et al.
Published: (1995)

The induction of intercellular adhesion molecule 1 (ICAM-1) expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor alpha, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation.
by: Frohman, E, et al.
Published: (1989)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
by: Feldmann, M, et al.
Published: (2020)

The role of receptors for tumour necrosis factor-alpha in the induction of human polymorphonuclear neutrophil chemiluminescence.
by: Zeman, K, et al.
Published: (1996)

Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
by: Scallon, B, et al.
Published: (1995)

Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma
by: Franziska Werner, et al.
Published: (2021-07-01)

A phase II trial using etanercept, a recombinant tumour necrosis factor antagonist, in metastatic breast cancer
by: Forster, MD, et al.
Published: (2002)

Efficacy and Safety of Tumour Necrosis Factor-α Antagonists for Folliculitis Decalvans: A Retrospective Case-series Pilot Study
by: Aurore Dupont, et al.
Published: (2023-03-01)